CTRN vs NBIX · rev $753.1M vs P/E 45, rev $2.36B
Citi Trends Inc (CTRN) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Citi Trends Inc (CTRN) is a apparel retail company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CTRN revenue for 2025-02-01 was $753.1M. Net income was -$43.2M. Revenue was up 0.7% from 2024-02-03 to 2025-02-01. CTRN currently screens at market cap $258.4M.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
CTRN currently screens at market cap $258.4M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the CTRN and NBIX stock pages for the full models.
Not investment advice.